Blaine Templeman, Executive VP, General Counsel at ADURO BIOTECH, INC. (ADRO), sold 2,884 shares at $8.25 ($24K) on 2017-12-18, disclosed to the SEC on 2017-12-20.
Scheduled sale ($24k) by Executive VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADRO | SELL | 2019-12-16 | $1K | — | Filing → |
| ADRO | SELL | 2019-09-17 | $17K | — | Filing → |
| ADRO | SELL | 2018-12-14 | $4K | — | Filing → |